Mohs micrographic surgery for basal cell carcinoma: evaluation of the indication criteria and predictive factors for extensive subclinical spread
Authors:
- 28 January 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 174 (4) , 847-852
Abstract
The incidence of basal cell carcinoma (BCC) is rising and BCC treatment has an important impact on healthcare budget. Mohs micrographic surgery (MMS) has the highest 5-year cure rate but is an expensive technique. To study the indication criteria for MMS, using a series of 1062 patients treated for facial BCCs between 1998 and 2011. The accuracy of the indication criteria was evaluated by comparing the characteristics of BCC requiring one vs. more than one round of MMS. Predictors for extensive subclinical spread (three or more rounds) were examined using the preoperative patient and all tumour characteristics. BCCs with a surface > 1 cm(2) and aggressive histology (morphoeaform and micronodular), and a patient age > 80 years are strong predictors for two or more rounds of MMS being required. Extensive subclinical spread was present in recurrent tumours, morphoeaform BCC or BCC with mixed histology. We found that tumour size and aggressive histology are the strongest indication criteria for MMS. Recurrence and aggressive histology are predictors for extensive subclinical spread but not for two or more rounds of MMS. Evidence-based indications for MMS are necessary to ensure cost-effective management of BCC.Keywords
Funding Information
- Universitair Ziekenhuis Gent
This publication has 17 references indexed in Scilit:
- Measuring current and future cost of skin cancer in EnglandJournal of Public Health, 2013
- Trends in Basal Cell Carcinoma Incidence Rates: A 37-Year Dutch Observational StudyJournal of Investigative Dermatology, 2013
- Basal cell carcinomas without histological confirmation and their treatment: an audit in four European regionsBritish Journal of Dermatology, 2012
- Trends in the incidence of basal cell carcinoma by histopathological subtypeJournal of the European Academy of Dermatology and Venereology, 2010
- Dermatological surgery: a comparison of activity and outcomes in primary and secondary careBritish Journal of Dermatology, 2009
- Management of basal cell carcinoma by surveyed dermatologists in ScotlandClinical and Experimental Dermatology, 2006
- Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literatureBritish Journal of Dermatology, 2004
- A prospective study of Mohs’ micrographic surgery in two English centresBritish Journal of Dermatology, 1997
- Mohs Surgery Is the Treatment of Choice for Recurrent (Previously Treated) Basal Cell CarcinomaThe Journal of Dermatologic Surgery and Oncology, 1989
- Long‐Term Recurrence Rates in Previously Untreated (Primary) Basal Cell Carcinoma: Implications for Patient Follow‐UpThe Journal of Dermatologic Surgery and Oncology, 1989